Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery

References

• Ahmed F, Discher DE. 2004. Self-porating polymersomes of PEG–PLA and PEG–PCL: hydrolysis-triggered controlled release vesicles. J Control Release. 96:37–53.
   PubMed Web of Science ®Google Scholar
• Ahmed F, Pakunlu RI, Srinivas G, Brannan A, Bates F, Klein ML, et al. 2006. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol Pharm. 3:340–350.
   PubMed Web of Science ®Google Scholar
• Arbit E, Goldberg M, Gomez-Orellana I, Majuru S. 2006. Oral heparin: status review. Thromb J. 4:6.
   PubMedGoogle Scholar
• Aungst BJ, Rogers NJ. 1988. Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm Res. 5:305–308.
   PubMed Web of Science ®Google Scholar
• Bagre AP, Jain K, Jain NK. 2013. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: In vitro and in vivo assessment. Int J Pharm. 456:31–40.
   PubMed Web of Science ®Google Scholar
• Barakat NA, Sheikh FA, Al-Deyab SS, Chronakis IS, Yong Kim H. 2011. Biologically active polycaprolactone/titanium hybrid electrospun nanofibers for hard tissue engineering. Sci Adv Mater. 3:730–734.
   Web of Science ®Google Scholar
• Bargoni A, Cavalli R, Caputo O, Fundarò A, Gasco MR, Zara GP. 1998. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res. 15:745–750.
   PubMed Web of Science ®Google Scholar
• Bartenschlager R, Penin F, Lohmann V, André P. 2011. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 19:95–103.
   PubMed Web of Science ®Google Scholar
• Bathfield M, Daviot D, D’Agosto F, Spitz R, Ladavière C, Charreyre M-T, Delair T. 2008. Synthesis of lipid-α-end-functionalized chains by RAFT polymerization. Stabilization of lipid/polymer particle assemblies. Macromolecules. 41:8346–8353.
   Web of Science ®Google Scholar
• Baughman RA, Kapoor SC, Agarwal RK, Kisicki J, Catella-Lawson F, FitzGerald GA. 1998. Oral delivery of anticoagulant doses of heparin a randomized, double-blind, controlled study in humans. Circulation. 98:1610–1615.
   PubMed Web of Science ®Google Scholar
• Bergstrand N, Arfvidsson MC, Kim J-M, Thompson DH, Edwards K. 2003. Interactions between pH-sensitive liposomes and model membranes. Biophys Chem. 104:361–379.
   PubMed Web of Science ®Google Scholar
• Bershteyn A, Chaparro J, Yau R, Kim M, Reinherz E, Ferreira-Moita L, Irvine DJ. 2008. Polymer-supported lipid shells, onions, and flowers. Soft Matter. 4:1787–1791.
   PubMed Web of Science ®Google Scholar
• Bhavsar MD, Tiwari SB, Amiji MM. 2006. Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J Control Release. 110:422–430.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, McGinity J. 1988. Solvent selection in the preparation of poly (DL-lactide) microspheres prepared by the solvent evaporation method. Int J Pharm. 43:179–186.
   Web of Science ®Google Scholar
• Brayden DJ, Baird AW. 2004. Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery. Adv Drug Deliv Rev. 56:721–726.
   PubMed Web of Science ®Google Scholar
• Carmona-Ribeiro A, Herrington T. 1993. Phospholipid adsorption onto polystyrene microspheres. J Colloid Interface Sci. 156:19–23.
   Web of Science ®Google Scholar
• Carmona-Ribeiro A, Midmore B. 1992. Synthetic bilayer adsorption onto polystyrene microspheres. Langmuir. 8:801–806.
   Web of Science ®Google Scholar
• Casey JR, Grinstein S, Orlowski J. 2009. Sensors and regulators of intracellular pH. Nat Rev Mol Cell Biol. 11:50–61.
   PubMed Web of Science ®Google Scholar
• Cepraga C. 2012. Conjugués polymère-chromophores biphotoniques greffés sur des nanoparticules d'or comme sondes fluorescentes pour la bioimagerie et la photothérapie dynamique. INSA de Lyon.
   Google Scholar
• Chakraborty S, Shukla D, Mishra B, Singh S. 2009. Lipid–an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm. 73:1–15.
   PubMed Web of Science ®Google Scholar
• Chandy T, Rao GH, Wilson RF, Das GS. 2002. Delivery of LMW heparin via surface coated chitosan/peg-alginate microspheres prevents thrombosis. Drug Deliv. 9:87–96.
   PubMed Web of Science ®Google Scholar
• Chang DP, Jankunec M, Barauskas J, Tiberg F, Nylander T. 2012. Adsorption of lipid liquid crystalline nanoparticles on cationic, hydrophilic, and hydrophobic surfaces. ACS Appl Mater Interfaces. 4:2643–2651.
   PubMed Web of Science ®Google Scholar
• Chen M-C, Wong H-S, Lin K-J, Chen H-L, Wey S-P, Sonaje K, et al. 2009. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin. Biomaterials. 30:6629–6637.
   PubMed Web of Science ®Google Scholar
• Cheow WS, Hadinoto K. 2011. Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles. Colloids Surf B Biointerfaces. 85:214–220.
   PubMed Web of Science ®Google Scholar
• Chiang W-H, Hsu Y-H, Tang F-F, Chern C-S, Chiu H-C. 2010. Temperature/pH-induced morphological regulations of shell cross-linked graft copolymer assemblies. Polymer. 51:6248–6257.
   Web of Science ®Google Scholar
• Chidambaram M, Krishnasamy K. 2014. .Modifications to the conventional nanoprecipitation technique: an approach to fabricate narrow sized polymeric nanoparticles.Adv Pharm Bull. 4:205–208.
   PubMedGoogle Scholar
• Connor J, Yatvin MB, Huang L. 1984. pH-sensitive liposomes: acid-induced liposome fusion. Proc Natl Acad Sci. 81:1715–1718.
   PubMed Web of Science ®Google Scholar
• Coombes A, Yeh M-K, Lavelle E, Davis S. 1998. The control of protein release from poly (DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. J Control Release. 52:311–320.
   PubMed Web of Science ®Google Scholar
• Davis ME. 2009. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm. 6:659–668.
   PubMed Web of Science ®Google Scholar
• Deok Kong S, Sartor M, Jack Hu C-M, Zhang W, Zhang L, Jin S. 2013. Magnetic field activated lipid–polymer hybrid nanoparticles for stimuli-responsive drug release. Acta Biomater. 9:5447–5452.
   PubMed Web of Science ®Google Scholar
• des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V. 2006. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 116:1–27.
   PubMed Web of Science ®Google Scholar
• Fahmy TM, Samstein RM, Harness CC, Mark Saltzman W. 2005. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials. 26:5727–5736.
   PubMed Web of Science ®Google Scholar
• Fang D-L, Chen Y, Xu B, Ren K, He Z-Y, He L-L, et al. 2014. Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy. Int J Mol Sci. 15:3373–3388.
   PubMed Web of Science ®Google Scholar
• Fang RH, Aryal S, Hu C-MJ, Zhang L. 2010. Quick synthesis of lipid− polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir. 26:16958–16962.
   PubMed Web of Science ®Google Scholar
• Florence AT. 1997. The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual. Pharm Res. 14:259–266.
   PubMed Web of Science ®Google Scholar
• Florence AT. 2004. Issues in oral nanoparticle drug carrier uptake and targeting. J Drug Target. 12:65–70.
   PubMed Web of Science ®Google Scholar
• Florence AT, Hillery AM, Hussain N, Jani PU. 1995. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Release. 36:39–46.
   Web of Science ®Google Scholar
• Florence AT, Hussain N. 2001. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev. 50:S69–S89.
   PubMed Web of Science ®Google Scholar
• Gabizon AA. 2001. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 19:424–436.
   PubMed Web of Science ®Google Scholar
• Gardon JL. 1966. The influence of polarity upon the solubility parameter concept. J Paint Technol. 38:43–57.
   Google Scholar
• Gasco MR. 1993. Method for producing solid lipid microspheres having a narrow size distribution. Google Patents, US 5250236A.
   Google Scholar
• Gerasimov OV, Boomer JA, Qualls MM, Thompson DH. 1999. Cytosolic drug delivery using pH-and light-sensitive liposomes. Adv Drug Deliv Rev. 38:317–338.
   PubMed Web of Science ®Google Scholar
• Grossiord JL, Seiler M. 1999. Multiple Emulsions: Structure Properties and Applications Paris: Editions de Sante.
   Google Scholar
• Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF, et al. 2008. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci. 105:2586–2591.
   PubMed Web of Science ®Google Scholar
• Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE. 2007. Characterization of nanoparticles for therapeutics. Nanomedicine. 2:789–803.
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. 2006. 23 Nanoparticles for Drug Delivery. Philadelphia, Pennsylvania: Drexel University.
   Google Scholar
• Houchin M, Topp E. 2008. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm Sci. 97:2395–2404.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Kaushal S, Cao HST, Aryal S, Sartor M, Esener S, et al. 2010. Half-antibody functionalized lipid− polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm. 7:914–920.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. 2011. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci. 108:10980–10985.
   PubMed Web of Science ®Google Scholar
• Jahanshahi M, Babaei Z. 2008. Protein nanoparticle: a unique system as drug delivery vehicles. Afr J Biotechnol. 7.
   Google Scholar
• Jain K. 2008. Nanomedicine: application of nanobiotechnology in medical practice. Med Princ Pract. 17:89–101.
   PubMed Web of Science ®Google Scholar
• Jain S, Valvi PU, Swarnakar NK, Thanki K. 2012. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol Pharm. 9:2542–2553.
   PubMed Web of Science ®Google Scholar
• Jelesarov I, Bosshard HR. 1999. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J Mol Recognit. 12:3–18.
   PubMed Web of Science ®Google Scholar
• Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. 2000a. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 49:211–218.
   PubMed Web of Science ®Google Scholar
• Jenning V, Thünemann AF, Gohla SH. 2000b. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm. 199:167–177.
   PubMed Web of Science ®Google Scholar
• Johnsson M, Edwards K. 2003. Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly (ethylene glycol)-phospholipids. Biophys J. 85:3839–3847.
   PubMed Web of Science ®Google Scholar
• Joshi N, Saha R, Shanmugam T, Balakrishnan B, More P, Banerjee R. 2013. Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel. Biomacromolecules. 14:2272–2282.
   PubMed Web of Science ®Google Scholar
• Kalepu S, Manthina M, Padavala V. 2013. Oral lipid-based drug delivery systems–an overview. Acta Pharm Sin B. 3:361–372.
   Web of Science ®Google Scholar
• Kaneko Y, Nakamura S, Sakai K, Kikuchi A, Aoyagi T, Sakurai Y, Okano T. 1998. Deswelling mechanism for comb-type grafted poly (N-isopropylacrylamide) hydrogels with rapid temperature responses. Polym Gels Netwo. 6:333–345.
   Web of Science ®Google Scholar
• Katanec D, Pavelić B, Ivasović Z. 2004. Efficiency of polylactide/ polyglycolide copolymers bone replacements in bone defects healing measured by densitometry. Coll Antropol. 28:331–336.
   PubMedGoogle Scholar
• Kol N, Shi Y, Tsvitov M, Barlam D, Shneck RZ, Kay MS, Rousso I. 2007. A stiffness switch in human immunodeficiency virus. Biophys J. 92:1777–1783.
   PubMed Web of Science ®Google Scholar
• Kong SD, Zhang W, Lee JH, Brammer K, Lal R, Karin M, Jin S. 2010. Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release. Nano Lett. 10:5088–5092.
   PubMed Web of Science ®Google Scholar
• Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci. 90:4942–4946.
   PubMed Web of Science ®Google Scholar
• Kreuter J. 1991. Peroral administration of nanoparticles. Adv Drug Deliv Rev. 7:71–86.
   Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 75:1–18.
   PubMed Web of Science ®Google Scholar
• Kumbhar DD, Pokharkar VB. 2013. Physicochemical investigations on an engineered lipid–polymer hybrid nanoparticle containing a model hydrophilic active, zidovudine. Colloids Surf A Physicochem Eng Aspects. 436:714–725.
   Web of Science ®Google Scholar
• Lallana E, Sousa-Herves A, Fernandez-Trillo F, Riguera R, Fernandez-Megia E. 2012. Click chemistry for drug delivery nanosystems. Pharm Res. 29:1–34.
   PubMed Web of Science ®Google Scholar
• Lee S-M, Chen H, Dettmer CM, O’Halloran TV, Nguyen ST. 2007. Polymer-caged lipsomes: a pH-responsive delivery system with high stability. J Am Chem Soc. 129:15096–15097.
   PubMed Web of Science ®Google Scholar
• Lee S-M, Chen H, O’Halloran TV, Nguyen ST. 2009. “Clickable” polymer-caged nanobins as a modular drug delivery platform. J Am Chem Soc. 131:9311–9320.
   PubMed Web of Science ®Google Scholar
• Li J, He Y-Z., Li W, Shen Y-Z., Li Y-R, Wang Y-F. 2010. A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacol Sin. 31:509–514.
   PubMed Web of Science ®Google Scholar
• Li Z, Guan J. 2011. Thermosensitive hydrogels for drug delivery. Expert Opin Drug Deliv. 8:991–1007.
   PubMed Web of Science ®Google Scholar
• Liechty WB, Peppas NA. 2012. Expert opinion: responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm. 80: 241–246.
   PubMed Web of Science ®Google Scholar
• Lin JJ, Silas JA, Bermudez H, Milam VT, Bates FS, Hammer DA. 2004. The effect of polymer chain length and surface density on the adhesiveness of functionalized polymersomes. Langmuir. 20:5493–5500.
   PubMed Web of Science ®Google Scholar
• Lincopan N, Espíndola N, Vaz A, Carmona-Ribeiro A. 2007. Cationic supported lipid bilayers for antigen presentation. Int J Pharm. 340:216–222.
   PubMed Web of Science ®Google Scholar
• Lincopan N, Santana MR, Faquim-Mauro E, da Costa MH, Carmona-Ribeiro AM. 2009. Silica-based cationic bilayers as immunoadjuvants. BMC Biotechnol. 9:5.
   PubMed Web of Science ®Google Scholar
• Ling G, Zhang P, Zhang W, Sun J, Meng X, Qin Y, et al. 2010. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition. J Control Release. 148:241–248.
   PubMed Web of Science ®Google Scholar
• Luong A, Issarapanichkit T, Kong SD, Fong R, Yang J. 2010. pH-sensitive, N-ethoxybenzylimidazole (NEBI) bifunctional crosslinkers enable triggered release of therapeutics from drug delivery carriers. Org Biomol Chem. 8:5105–5109.
   PubMed Web of Science ®Google Scholar
• Lutz KL, Siahaan TJ. 1997. Molecular structure of the apical junction complex and its contribution to the paracellular barrier. J Pharm Sci. 86:977–984.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. 2001. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 47:165–196.
   PubMed Web of Science ®Google Scholar
• Meng F, Hiemstra C, Engbers GH, Feijen J. 2003. Biodegradable polymersomes. Macromolecules. 36:3004–3006.
   Web of Science ®Google Scholar
• Miller R, Fainerman V, Makievski A, Krägel J, Grigoriev D, Kazakov V, Sinyachenko O. 2000. Dynamics of protein and mixed protein/ surfactant adsorption layers at the water/fluid interface. Adv Colloid Interface Sci. 86:39–82.
   PubMed Web of Science ®Google Scholar
• Montasser I, Shahgaldian P, Perret F, Coleman AW. 2013. Solid lipid nanoparticle-based calix [n] arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization. Int J Mol Sci. 14:21899–21942.
   PubMed Web of Science ®Google Scholar
• Mu H, Holm R, Müllertz A. 2013. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm. 453: 215–224.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm. 50:161–177.
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. 2002. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 242:121–128.
   PubMed Web of Science ®Google Scholar
• Müller RH, Rühl D, Runge SA. 1996. Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. Int J Pharm. 144:115–121.
   Web of Science ®Google Scholar
• Napoli A, Valentini M, Tirelli N, Müller M, Hubbell JA. 2004. Oxidation-responsive polymeric vesicles. Nat Mater. 3:183–189.
   PubMed Web of Science ®Google Scholar
• Nielsen SO, Lopez CF, Srinivas G, Klein ML. 2004. Coarse grain models and the computer simulation of soft materials. J Phys Condens Matter. 16:R481.
   Web of Science ®Google Scholar
• Novoa GAG, Heinämäki J, Mirza S, Antikainen O, Iraizoz Colarte A, Suzarte Paz A, Yliruusi J. 2005. Physical solid-state properties and dissolution of sustained-release matrices of polyvinylacetate. Eur J Pharm Biopharm. 59:343–350.
   PubMed Web of Science ®Google Scholar
• O’Halloran TV, Ahn R, Hankins P, Swindell E, Mazar AP. 2013. The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single target. Theranostics. 3:496.
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 113:823.
   PubMed Web of Science ®Google Scholar
• Osaka T, Nakanishi T, Shanmugam S, Takahama S, Zhang H. 2009. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloids Surf B Biointerfaces. 71:325–330.
   PubMed Web of Science ®Google Scholar
• Pandey R, Sharma S, Khuller G. 2005. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis. 85:415–420.
   PubMed Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones S, Dobson J. 2003. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 36:R167.
   Web of Science ®Google Scholar
• Pautot S, Frisken BJ, Weitz D. 2003. Engineering asymmetric vesicles. Proc Natl Acad Sci. 100:10718–10721.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 6:231–248.
   PubMed Web of Science ®Google Scholar
• Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Alonso M. 2006. Chitosan–PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree. J Control Release. 111:299–308.
   PubMed Web of Science ®Google Scholar
• Qin S, Geng Y, Discher DE, Yang S. 2006. Temperature-controlled assembly and release from polymer vesicles of poly (ethylene oxide)-block-poly (N-isopropylacrylamide). Adv Mater. 18:2905–2909.
   Web of Science ®Google Scholar
• Rowe R. 1989. Polar/non-polar interactions in the granulation of organic substrates with polymer binding agents. Int J Pharm. 56:117–124.
   Web of Science ®Google Scholar
• Saad M, Garbuzenko OB, Minko T. 2008. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine. 3:761–776.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. 2005. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm. 2: 373–383.
   PubMed Web of Science ®Google Scholar
• Sanjula B, Shah FM, Javed A, Alka A. 2009. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target. 17:249–256.
   PubMed Web of Science ®Google Scholar
• Sanna V, Kirschvink N, Gustin P, Gavini E, Roland I, Delattre L, Evrard B. 2004. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech. 5:17–23.
   Web of Science ®Google Scholar
• Sanvicens N, Marco MP. 2008. Multifunctional nanoparticles– properties and prospects for their use in human medicine. Trends Biotechnol. 26:425–433.
   PubMed Web of Science ®Google Scholar
• Schenderlein S, Lück M, Müller B. 2004. Partial solubility parameters of poly (D, L-lactide-co-glycolide). Int J Pharm. 286:19–26.
   PubMed Web of Science ®Google Scholar
• Semete B, Booysen L, Lemmer Y, Kalombo L, Katata L, Verschoor J, Swai HS. 2010. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine. 6:662–671.
   PubMed Web of Science ®Google Scholar
• Shegokar R, Singh K, Müller R. 2011. Production & stability of stavudine solid lipid nanoparticles—From lab to industrial scale.Int J Pharm. 416:461–470.
   PubMed Web of Science ®Google Scholar
• Shi J, Xiao Z, Votruba AR, Vilos C, Farokhzad OC. 2011. Differentially charged hollow core/shell lipid–polymer–lipid hybrid nanoparticles for small interfering RNA delivery. Angew Chem Int Ed Engl. 123:7165–7169.
   Google Scholar
• Silva CO, Sarmento B, Reis CP. 2014. Oral Delivery of Biopharmaceuticals. Mucosal Delivery of Biopharmaceuticals. New York: Springer.
   Google Scholar
• Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S. 2010. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull. 58:650–655.
   PubMed Web of Science ®Google Scholar
• Souto EB, Doktorovova S. 2009. Solid lipid nanoparticle formulations: pharmacokinetic and biopharmaceutical aspects in drug delivery. Methods Enzymol. 464:105–129.
   PubMed Web of Science ®Google Scholar
• Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AG, Taylor D, et al. 1994. Surface modification of poly (lactide-co-glycolide) nanospheres by biodegradable poly (lactide)-poly (ethylene glycol) copolymers. Pharm Res. 11:1800–1808.
   PubMed Web of Science ®Google Scholar
• Sugiura S, Nakajima M, Iwamoto S, Seki M. 2001. Interfacial tension driven monodispersed droplet formation from microfabricated channel array. Langmuir. 17:5562–5566.
   Web of Science ®Google Scholar
• Sung JC, Padilla DJ, Garcia-Contreras L, VerBerkmoes JL, Durbin D, Peloquin CA, et al. 2009. Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res. 26:1847–1855.
   PubMed Web of Science ®Google Scholar
• Suri SS, Fenniri H, Singh B. 2007. Nanotechnology-based drug delivery systems. J Occup Med Toxicol. 2:16.
   PubMedGoogle Scholar
• Tanaka M, Sackmann E. 2005. Polymer-supported membranes as models of the cell surface. Nature. 437:656–663.
   PubMed Web of Science ®Google Scholar
• Tannock IF, Rotin D. 1989. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49:4373–4384.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter CJ. 2008. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev. 60:702–716.
   PubMed Web of Science ®Google Scholar
• Troutier A-L, Véron L, Delair T, Pichot C, Ladavière C. 2005. New insights into self-organization of a model lipid mixture and quantification of its adsorption on spherical polymer particles. Langmuir. 21:9901–9910.
   PubMed Web of Science ®Google Scholar
• Uchiyama T, Sugiyama T, Quan YS, Kotani A, Okada N, Fujita T, et al. 1999. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-Lauryl-βD-maltopyranoside. J Pharm Pharmacol. 51: 1241–1250.
   PubMed Web of Science ®Google Scholar
• Uchiyama T, Yamamoto A, Hatano H, Fujita T, Muranishi S. 1996. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane. Biol Pharm Bull. 19:1618.
   PubMed Web of Science ®Google Scholar
• Uekama K, Hirayama F, Irie T. 1998. Cyclodextrin drug carrier systems. Chem Rev. 98:2045–2076.
   PubMed Web of Science ®Google Scholar
• Valenta C, Auner BG. 2004. The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm. 58:279–289.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Kallinowski F, Okunieff P. 1989. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49:6449–6465.
   PubMed Web of Science ®Google Scholar
• Vidard L, Kovacsovics-Bankowski M, Kraeft S-K, Chen LB, Benacerraf B, Rock KL. 1996. Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J Immunol. 156:2809–2818.
   PubMed Web of Science ®Google Scholar
• Vieira DB, Carmona-Ribeiro AM. 2008. Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro. J Nanobiotechnol. 6:1–13.
   PubMedGoogle Scholar
• Vonarbourg A, Passirani C, Saulnier P, Benoit J-P. 2006. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials. 27:4356–4373.
   PubMed Web of Science ®Google Scholar
• Vriezema DM, Comellas Aragonès M, Elemans JA, Cornelissen JJ, Rowan AE, Nolte RJ. 2005. Self-assembled nanoreactors. Chemical Rev. 105:1445–1490.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Khar RK. 2004. Targeted and Controlled Drug Delivery: Novel Carrier Systems. New York: CBS publishers & distributors.
   Google Scholar
• Wahlgren M, Christensen KL, Jørgensen EV, Svensson A, Ulvenlund S. 2009. Oral-based controlled release formulations using poly (acrylic acid) microgels. Drug Dev Ind Pharm. 35:922–929.
   PubMed Web of Science ®Google Scholar
• Wang J, Ornek-Ballanco C, Xu J, Yang W, Yu X. 2012a. Preparation and characterization of vinculin-targeted polymer–lipid nanoparticle as intracellular delivery vehicle. Int J Nanomedicine. 8:39–46.
   PubMed Web of Science ®Google Scholar
• Wang Y, Kho K, Cheow WS, Hadinoto K. 2012b. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid–polymer hybrid nanoparticles. Int J Pharm. 424:98–106.
   PubMed Web of Science ®Google Scholar
• Ward PD, Tippin TK, Thakker DR. 2000. Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm Sci Technol Today. 3:346–358.
   PubMedGoogle Scholar
• Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. 2007. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev. 59:491–504.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY. 2006a. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. JPharmacol Exp Ther. 317:1372–1381.
   PubMed Web of Science ®Google Scholar
• Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z, et al. 2006b. A new polymer–lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res. 23:1574–1585.
   PubMed Web of Science ®Google Scholar
• Xie S, Wang S, Zhao B, Han C, Wang M, Zhou W. 2008. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 67:199–204.
   PubMed Web of Science ®Google Scholar
• Yu D-G, Shen X-X, Branford-White C, White K, Zhu L-M, Bligh SA. 2009. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers. Nanotechnology. 20:055104.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chan JM, Gu FX, Rhee J-W, Wang AZ, Radovic-Moreno AF, et al. 2008. Self-assembled lipid− polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2:1696–1702.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dou X, Jin T. 2010. Synthesis and self-assembly behavior of amphiphilic diblock copolymer dextran-block-poly (ϵ-caprolactone) (DEX-b-PC) in aqueous media. Express Polym Lett. 4.
   Web of Science ®Google Scholar